Evidence map›Paper›PMID 32953934›Full record

ArticleMolecular therapy. Methods & clinical development2020

CERE-120 Prevents Irradiation-Induced Hypofunction and Restores Immune Homeostasis in Porcine Salivary Glands.

Isabelle M A Lombaert, Vaishali N Patel, Christina E Jones, Derrick C Villier, Ashley E Canada, Matthew R Moore, Elsa Berenstein, Changyu Zheng, Corinne M Goldsmith, John A Chorini and 8 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Gene Therapeutic Delivery to the Salivary Glands.Advances in experimental medicine and biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Isabelle M A LombaertMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Vaishali N PatelMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Christina E JonesMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Derrick C VillierMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Ashley E CanadaMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Matthew R MooreMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Elsa BerensteinMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
Changyu ZhengTranslational Research Core, NIDCR, NIH, DHHS, Bethesda, MD 20892, USA.
Corinne M GoldsmithTranslational Research Core, NIDCR, NIH, DHHS, Bethesda, MD 20892, USA.
John A ChoriniAdeno-Associated Virus Section, NIDCR, NIH, DHHS, Bethesda, MD 20892, USA.
Daniel MartinGenomics and Computational Biology Core, NIDCR, NIH, DHHS, Bethesda, MD 20892, USA.
Lee ZoureliasGene Therapy Program, Department of Medicine, Division of Cardiovascular Medicine, Allegheny Health Network, Pittsburg, PA 15212, USA.
Mark G TrombettaDepartment of Oncology, Division of Radiation Oncology, Allegheny Health Network, Pittsburg, PA 15212, USA.
Paul C EdwardsDepartment of Oral Pathology, Medicine, and Radiology, Indiana University School of Dentistry, Indianapolis, IN 46202, USA.
Kathleen MeyerSangamo BioSciences, Inc., 501 Canal Blvd., Richmond, CA 94804.
Dale AndoSangamo BioSciences, Inc., 501 Canal Blvd., Richmond, CA 94804.
Michael J PassineauGene Therapy Program, Department of Medicine, Division of Cardiovascular Medicine, Allegheny Health Network, Pittsburg, PA 15212, USA.
Matthew P HoffmanMatrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
National Institute of Dental and Craniofacial Research · USAllegheny Health Network · USSangamo BioSciences (United States) · USUnited States Department of Health and Human Services · USIndiana University – Purdue University Indianapolis · US

Funding

Adeno-associated Virus Biology And Utilization For Gene TransferZIADE000695 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI CHIORINI, JAY · 2009 to 2025
$36.6M
Genomic and Computational Biology Support for NIDCD Intramural ResearchZICDC000086 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI MORELL, ROBERT J · 2015 to 2025
$19.8M
Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Progenitor/Stem Cell Function During Salivary Gland DevelopmentZIADE000722 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI HOFFMAN, MATTHEW · 2009 to 2023
$13.7M
NIDCR Annual Reports - Veterinary Resources CoreZIGDE000740 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI DAVIDSON, LAUREN · 2012 to 2025
$11.7M
Imaging CoreZICDE000750 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI DOYLE, ANDREW · 2019 to 2025
$6.9M
Ultrasound-Assisted AQP1 Gene Therapy for Functional Restoration of Salivary GlanR01DE022973 · NIDCR · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI PASSINEAU, MICHAEL J. · 2012 to 2015
$1.7M
Breaching the Epithelial Lining for Effective Salivary Gland Stem Cell Delivery in Clinical-Relevant SettingsR21DE028690 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOMBAERT, ISABELLE M.A. · 2019 to 2020
$439k
Intramural NIH HHS ZIA DE000695Intramural NIH HHS ZIA DE000722Intramural NIH HHS ZIC DC000086Intramural NIH HHS ZIC DE000750Intramural NIH HHS ZIG DE000740NIDCR NIH HHS R01 DE022973NIDCR NIH HHS R21 DE028690NIDCR NIH HHS T32 DE007057
6 · The paper itself

Abstract

Salivary gland hypofunction causes significant morbidity and loss of quality of life for head and neck cancer patients treated with radiotherapy. Preventing hypofunction is an unmet therapeutic need. We used an adeno-associated virus serotype 2 (AAV2) vector expressing the human neurotrophic factor neurturin (CERE-120) to treat murine submandibular glands either pre- or post-irradiation (IR). Treatment with CERE-120 pre-IR, not post-IR, prevented hypofunction. RNA sequencing (RNA-seq) analysis showed reduced gene expression associated with fibrosis and the innate and humoral immune responses. We then used a minipig model with CERE-120 treatment pre-IR and also compared outcomes of the contralateral non-IR gland. Analysis of gene expression, morphology, and immunostaining showed reduced IR-related immune responses and improved secretory mechanisms. CERE-120 prevented IR-induced hypofunction and restored immune homeostasis, and there was a coordinated contralateral gland response to either damage or treatment. CERE-120 gene therapy is a potential treatment for head and neck cancer patients to influence communication among neuronal, immune, and epithelial cells to prevent IR-induced salivary hypofunction and restore immune homeostasis.

Indexed as

AAV-neurturinCERE-120fibrosisgene therapyhead and neck cancerhumoral immunityinnate immunityirradiation damagesalivary glandsalivary hypofunction

Identifiers

PMID32953934
PMCPMC7479444
OpenAlexW3046890024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.